Eden Research (LON:EDEN) Stock Price Down 13.2% – Here’s What Happened

Eden Research plc (LON:EDEN) shares dropped 13.2% on Monday . The stock traded as low as GBX 2.26 ($0.03) and last traded at GBX 2.37 ($0.03). Approximately 1,775,147 shares changed hands during trading, an increase of 133% from the average daily volume of 762,776 shares. The stock had previously closed at GBX 2.73 ($0.04).

Eden Research Stock Down 13.2 %

The company has a debt-to-equity ratio of 1.26, a current ratio of 3.80 and a quick ratio of 2.42. The stock’s fifty day simple moving average is GBX 3.39 and its 200-day simple moving average is GBX 3.72. The stock has a market cap of £12.64 million, a P/E ratio of -8.30 and a beta of 0.92.

Insider Buying and Selling

In related news, insider Alexander John Abrey bought 540,540 shares of the company’s stock in a transaction on Tuesday, January 28th. The shares were purchased at an average cost of GBX 4 ($0.05) per share, with a total value of £21,621.60 ($27,934.88). Also, insider Lykele van der Broek bought 256,000 shares of the business’s stock in a transaction on Thursday, February 6th. The stock was bought at an average price of GBX 4 ($0.05) per share, for a total transaction of £10,240 ($13,229.97). In the last 90 days, insiders have purchased 964,487 shares of company stock valued at $3,690,001. Insiders own 14.02% of the company’s stock.

Eden Research Company Profile

Eden Research is the only UK-listed company focused on biopesticides for sustainable agriculture. It develops and supplies innovative biopesticide products and natural microencapsulation technologies to the global crop protection, animal health and consumer products industries.

Eden’s products are formulated with terpene active ingredients, based on natural plant defence metabolites.